Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome
Abstract The dopamine partial agonist aripiprazole is increasingly used to treat pathologies for which other antipsychotics are indicated because it displays fewer side effects, such as sedation and depression-like symptoms, than other dopamine receptor antagonists. Previously, we showed that aripip...
Saved in:
Main Authors: | Alexandre Salvador, Yulia Worbe, Cécile Delorme, Giorgio Coricelli, Raphaël Gaillard, Trevor W. Robbins, Andreas Hartmann, Stefano Palminteri |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/84f75f853f8449c68cf25317c55a8ed1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The sooner the better: clinical and neural correlates of impulsive choice in Tourette disorder
by: Cyril Atkinson-Clement, et al.
Published: (2021) -
Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?
by: Yulia Worbe, et al.
Published: (2010) -
Neurosurgical strategies for Gilles de la Tourette’s syndrome
by: Karim Mukhida, et al.
Published: (2008) -
Tics, Obsesiones y Síndrome de Gilles de la Tourette: Actualización Clínica
by: Miranda,Marcelo
Published: (2000) -
The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
by: Tara L. Moore, et al.
Published: (2021)